← Back to patent-cliff list
CAS 681249-57-0
2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine
Codes: FLUZO-002
Application context (from source-drug indications)
Breast cancerFluzoparibPeritoneal cancerFluzoparibOvarian cancerFluzoparibFallopian tube cancerFluzoparibProstate cancerFluzoparib三阴性乳腺癌Fluzoparib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Fluzoparib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid→2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine→Fluzoparib
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.